Idexx Laboratories Inc. (IDXX)
BMV
Closed
Aug 21, 2026
Day's Range
9,483.0052 wk Range
9,078.00Overview - IDXX - Idexx Laboratories Inc.
Key Statistics
Valuation
Enterprise Value
12.65T
P/E (Trailing)
‪39.36‬
PEG Ratio
‪2.28‬
Price / Sales (TTM)
‪164.07‬
Price / Book
‪27.06‬
EV / EBITDA
‪461.23‬
Profitability
Gross Margin
‪64.03%‬
Profit Margin
‪25.03%‬
Operating Margin
‪34.98%‬
Return on Assets
‪27.08%‬
Return on Equity
‪74.21%‬
Ownership
Shares Outstanding
78.87M
Float
78.50M
Held by Insiders
‪0.22%‬
Held by Institutions
‪96.82%‬
Price stats
Beta
‪1.54‬
50-Day Avg
‪9,887.89‬
200-Day Avg
‪10,884.17‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - IDXX - Idexx Laboratories Inc.
Peers - IDXX - Idexx Laboratories Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on BMV.
Profile Summary - IDXX - Idexx Laboratories Inc.
About
IDEXX Laboratories, Inc. is an American multinational corporation that develops, manufactures, and distributes diagnostic products and services for veterinary and environmental markets. The company specializes in solutions for companion animal health, including in-clinic laboratory analyzers like the Catalyst Dx…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
